Edward Andrle
Director/Board Member bei NEUROONE MEDICAL TECHNOLOGIES CORPORATION
Vermögen: 77 063 $ am 31.03.2024
Profil
Edward S.
Andrle is the founder of Myocor, Inc. He is currently an Independent Director at NeuroOne Medical Technologies Corp.
since 2020 and Vice President-Strategy & Business Development at Sorin Group Italia Srl since 2013.
Previously, he served as the Chief Executive Officer at StarFire Medical, Inc. from 2002 to 2009 and at TERAMed, Inc. from 1996 to 2001.
He was also a Vice President at Boston Scientific Corp.
from 1991 to 1996 and at Sorin SpA from 2012 to 2015.
Additionally, he held the position of General Manager-Neuromodulation at LivaNova Plc from 2018 to 2020.
Mr. Andrle received his undergraduate degree from the University of Notre Dame and an MBA from Stanford Graduate School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.01.2024 | 64 219 ( 0,25% ) | 77 063 $ | 31.03.2024 |
Aktive Positionen von Edward Andrle
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Director/Board Member | 18.02.2020 |
Sorin Group Italia Srl
 Sorin Group Italia Srl Medical SpecialtiesHealth Technology MicroPort CRM SRL engages in the production and distribution of medical devices. It specializes in the development of medical technologies for the treatment of cardiovascular diseases. The company is headquartered in Saluggia, Italy. | Corporate Officer/Principal | 01.01.2010 |
Ehemalige bekannte Positionen von Edward Andrle
| Unternehmen | Position | Ende |
|---|---|---|
| LIVANOVA PLC | Corporate Officer/Principal | 01.01.2020 |
| SORIN SPA | Corporate Officer/Principal | 01.09.2015 |
StarFire Medical, Inc.
 StarFire Medical, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, StarFire Medical, Inc. is a private company that manufactures therapeutic implantable devices. The company is based in Plymouth, MN. StarFire Medical was acquired by Nfocus Neuromedical, Inc. on March 06, 2008. | Chief Executive Officer | 01.01.2009 |
TERAMed, Inc.
 TERAMed, Inc. Medical SpecialtiesHealth Technology Part of Cardinal Health, Inc., TERAMed, Inc. designs, develops, and manufactures endovascular graft systems. The private company is based in Maple Grove, MN. TERAMed was acquired by Cordis Corp., part of Cardinal Health, Inc. from October 04, 2015 on December 18, 2001. | Chief Executive Officer | 01.01.2001 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01.01.1996 |
Ausbildung von Edward Andrle
| University of Notre Dame | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Distribution Services |
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Health Technology |
| LIVANOVA PLC | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Myocor, Inc.
 Myocor, Inc. Medical SpecialtiesHealth Technology Myocor, Inc. develops products for the treatment of mitral regurgitation and congestive heart failure. It has two products in clinical trials that are designed to improve the pumping efficiency of the heart and thus improve the quality of life of patients. The company was founded in 1996 by Cyril J. Schweich and Todd Mortier and is headquartered in Maple Grove, MN. | Health Technology |
StarFire Medical, Inc.
StarFire Medical, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, StarFire Medical, Inc. is a private company that manufactures therapeutic implantable devices. The company is based in Plymouth, MN. StarFire Medical was acquired by Nfocus Neuromedical, Inc. on March 06, 2008. | Health Technology |
TERAMed, Inc.
TERAMed, Inc. Medical SpecialtiesHealth Technology Part of Cardinal Health, Inc., TERAMed, Inc. designs, develops, and manufactures endovascular graft systems. The private company is based in Maple Grove, MN. TERAMed was acquired by Cordis Corp., part of Cardinal Health, Inc. from October 04, 2015 on December 18, 2001. | Health Technology |
Sorin SpA
 Sorin SpA Medical SpecialtiesHealth Technology Sorin SpA engages in the research, development, and manufacture of technology products for the treatment of cardiovascular diseases. It operates through the Cardiac Surgery and Cardiac Rhythm business segments. The Cardiac Surgery segment involves in the production and marketing of single-use biomedical devices, systems used to ensure out-of-body circulation in cardiac surgical procedures, and implantable prosthetics to replace or repair heart valves. The Cardiac Rhythm segment deals with the production and marketing of implantable devices and monitoring equipment and accessories to protect against heartbeat disorders. The company was founded in 1956 and is headquartered in Milan, Italy. | Health Technology |
MD Start SA
 MD Start SA BiotechnologyHealth Technology MD Start SA develops medical device technology. It has collaboration between venture capital, institutional investors and industry to the development of innovative medtech ideas in Europe. The company was founded by Tim Lenihanin 2010 and is headquartered in Paris, France. | Health Technology |
Sorin Group Italia Srl
Sorin Group Italia Srl Medical SpecialtiesHealth Technology MicroPort CRM SRL engages in the production and distribution of medical devices. It specializes in the development of medical technologies for the treatment of cardiovascular diseases. The company is headquartered in Saluggia, Italy. | Health Technology |
